Skip to main content
Ships fully reconstituted · no mixing, no powder, no bacteriostatic water
All peptides
Tesamorelin
Growth Hormone

Tesamorelin

Ships fully reconstituted · no mixing, no powder, no bacteriostatic water

Metabolic Optimization Peptide

Targets visceral fat reduction through natural growth hormone stimulation.

Choose your supply

Physician-reviewed · charged only after your prescription is approved
Free shipping over $350 · compounded in a U.S. pharmacy
Secure checkout · 256-bit encryption

Frequently paired with

What it supports

  • Reduces visceral (abdominal) fat
  • Improves metabolic function
  • Preserves lean muscle mass
  • Enhances body composition
  • Supports healthy lipid profiles
  • Increases energy levels
  • Improves overall vitality

The details

Administration
Subcutaneous injection
Format
2mg/mL, 5mL vial
Typical dosing
2mg subcutaneously daily
Best for
Visceral fat reduction, body composition
Pairs well with
Ipamorelin, MOTS-C
Tesamorelin works by binding to growth hormone-releasing hormone receptors in the pituitary gland, triggering the natural release of growth hormone. This promotes lipolysis (fat breakdown) particularly in visceral fat deposits while preserving lean muscle mass.

How it works

Signal

Tesamorelin is given as a single daily subcutaneous injection — usually in the morning — on a provider-determined schedule.

Cellular response

Tesamorelin binds GHRH receptors in the pituitary gland, triggering the natural release of growth hormone. That promotes lipolysis (fat breakdown) particularly in visceral fat deposits, while preserving subcutaneous fat and lean muscle mass.

Outcome

Over the following weeks most people notice small energy and sleep changes first (weeks 1–2), then a looser waistband and better recovery (weeks 3–6), then measurable waist-circumference reduction and improved bloodwork (weeks 6–12). Your provider may check IGF-1 along the way.

Research highlights

FDA-approved for HIV-associated lipodystrophy

Clinical studies show significant reduction in visceral fat

Research demonstrates improved triglyceride levels

Well-established safety profile from clinical trials

Research summaries are provided for educational context and are not a promise of results. Talk with your provider about what to expect.

Sources & references

  • Significant visceral fat reduction

    Falutz J et al. J Clin Endocrinol Metab. 2004.

    View source
  • Pivotal Phase III trial

    Falutz J et al. N Engl J Med. 2007;357:2359–2370.

    View source
  • Long-term metabolic effects

    Stanley TL et al. HIV Med. 2018.

    View source

Common questions

Important safety information

Tesamorelin is available by prescription only and is dispensed after a licensed provider reviews your medical screening and determines it is appropriate for you. Compounded medications are prepared by a licensed U.S. pharmacy and are not FDA-approved products. Tell your provider about your full medical history and any medications you take.

  • Generally well-tolerated with minimal side effects
  • May cause temporary injection site reactions
  • Should not be used during pregnancy or breastfeeding
  • Requires licensed provider supervision and monitoring